Neutrophils are the most abundant type of white blood cells in humans and animals and form an integral part of the immune system. Neutrophils are created on
demand by the body to counter single pathogens like a bacteria or virus. Single cell pathogens cannot regulate their oxygen content like mammal cells can.
So when these white blood cells surround the pathogen, they generate and release an oxy-chlorine compound. This process is called an oxidative burst and kills
Vetericyn contains compounds similar to those produced by these white blood cells to destroy the pathogen. But it does not harm other surrounding tissue and
actually creates an environment that is most conducive to healing. Vetericyn's active ingredient utilizes FDA cleared Microcyn Technology to produce a stable,
electrolyzed saline solution for the treatment of wounds, hot spots, fungus, rain rot and other dermal irritations and abrasions. In addition to eradication of
infection, the patented Microcyn Technology has also demonstrated the ability to speed healing through the increase of oxygen and blood flow to a wound site as
well as reduction of inflammation.
Microcyn Technology has been successfully used on over 1 million humans worldwide without a single report of a serious adverse affect. Vetericyn is backed by
over 25 clinical studies including two on large animals (bovine conjunctivitis and bovine throat ailments). This unparalleled wound treatment is now available for
animal health through Vetericyn.